MEDi Robot for Pain Management at Induction

April 26, 2021 updated by: Tanya Beran, University of Calgary

Efficacy of a Preparation Intervention for the Management of Children's Pain and Fear During Induction: Help From a Robot Named MEDi

The purpose of this study is to determine if a preparation teaching intervention before IV insertion, taught by MEDi to children and their parents, will lead to lower levels of expected and experienced pain and fear and less distressing pain memories, as compared to children who receive standard care. In addition, it will be examined whether this preparation intervention will lead to greater parental self-efficacy, less anxiety, and less distressing pain memories as compared to controls.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The primary aim is to determine the impact of using a humanoid robot in comparison to standard care. This proposal describes the first study in the world to test such novel technology for preparation teaching intervention before IV insertion. This work builds on previous research conducted by the research team and represents a logical next step for this collaborative group. This project team includes established and emerging leaders in pain management research. This will ensure successful implementation and completion of the project. These methods of teaching preparation have the potential for widespread application to other medical procedures and clinical settings (eg. oncology dentistry) and lead to improved health outcomes for children by easing their suffering and improving the quality of their healthcare encounters.

1.2 Research Questions

Research Question 1.) Does preparation administered by a humanoid robot (MEDi) reduce expectancies and experience of pain and fear of IV insertion in children?

Hypothesis 1.) Children who receive preparation by MEDi will report expecting and experiencing lower levels of fear and pain at IV insertion as compared to youth receiving standard care.

Research Question 2.) Does preparation administered by MEDi lead to higher self-efficacy and lower anxiety in parents of children undergoing IV insertion?

Hypothesis 2.) Parents of children who receive preparation by MEDi will report higher levels of self-efficacy and lower anxiety at their children's IV insertion as compared to youth receiving standard care.

Research Question 3.) Do children who receive preparation administered by MEDi and their parents have more accurate and positively estimated memories of pain and fear as compared to youth receiving standard care and their parents?

Hypothesis 3.) Children who receive preparation administered by MEDi and their parents will report more accurate and positively estimated memories of pain and fear as compared to youth receiving standard care and their parents.

Research Question 4.) Do children who receive preparation administered by MEDi prior to IV insertion and their parents expect to experience less pain, fear, anxiety, and higher self-efficacy in pain coping at future needle procedures as compared to youth receiving standard care and their parents?

Hypothesis 4.) Children who receive preparation administered by MEDi prior to IV insertion and their parents will report expecting to experience lower pain, fear, and anxiety and higher self-efficacy in pain coping at future needle procedures as compared to youth receiving standard care and their parents.

2.1 Study Design & Setting

This study is a single-centre prospective randomized, controlled, two-armed trial: (1) humanoid robot, MEDi, provides preparation for intravenous placement; and (2) standard care. Patients will be recruited from day surgery at the Alberta Children's Hospital Calgary, AB. This study will follow the high methodological standards for reporting RCTs according to the Consolidated Standards of Reporting Trials guidelines - extension for nonpharmacological treatments and this trial will be registered with clinicaltrials.gov.

2.2. Study Population

Legal guardians and/or patients with the ability to understand the study will be asked to provide written informed consent prior to participation. Day surgery patients, between the ages of 4-12 years old who are presenting for general surgery under general anesthesia, and in the American Society of Anesthesiologists class 1 or 2, will be included.

Study Type

Interventional

Enrollment (Anticipated)

137

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alberta
      • Calgary, Alberta, Canada, T3B 6A8
        • Alberta Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 12 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • presenting for general surgery under general anesthesia, and in the American Society of Anesthesiologists class 1 or 2

Exclusion Criteria:

  • patient presenting for day surgery
  • patient requires an intravenous placed in day surgery unit
  • patient cognitively unable to self-report pain
  • patient with a hearing or visual impairment or developmental disability that precludes self-reporting ability
  • family or child that is unable to communicate in English
  • previous allergic reaction to propofol or lidocaine

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control
No intervention
Experimental: robot
Humanoid robot interacts with child, teaching breathing and coping strategies.
Humanoid robot programmed with cognitive-behavioral interventions such as role modeling, teaching coping strategies, positive reinforcement, parent encouragement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
child's pain
Time Frame: at moment of child's IV start
Faces Pain Scale-Revised (FPS-R) (Hicks, 2001)
at moment of child's IV start

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
child's fear
Time Frame: at the moment of OR entry
Children's Fear Scale (McMurtry, Noel, Chambers, & McGrath, 2011)
at the moment of OR entry
parent self-efficacy
Time Frame: 30 mins to 3 hours before induction
use 0-10 numerical rating scales to report the degree to which they feel self-efficacy in their ability to help their child manage their pain and fear
30 mins to 3 hours before induction
parent anxiety
Time Frame: 30 mins to 3 hours before induction
Parents will be asked to report on their own level of anxiety during the needle procedure using a 0-10 NRS ranging from 0 ('not at all nervous or anxious') to 10 ('most nervous or anxious').
30 mins to 3 hours before induction
children's memory
Time Frame: 2 weeks after child's induction
, parents and children will be asked to provide their free recall of each of those periods using open-ended prompts
2 weeks after child's induction
parents' memory
Time Frame: 2 weeks after child's induction
, parents and children will be asked to provide their free recall of each of those periods using open-ended prompts
2 weeks after child's induction

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 8, 2016

Primary Completion (Actual)

May 25, 2018

Study Completion (Actual)

May 25, 2018

Study Registration Dates

First Submitted

July 28, 2016

First Submitted That Met QC Criteria

August 5, 2016

First Posted (Estimate)

August 8, 2016

Study Record Updates

Last Update Posted (Actual)

April 27, 2021

Last Update Submitted That Met QC Criteria

April 26, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • REB16-0148

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Therapy

Clinical Trials on Humanoid Robot MEDi

3
Subscribe